###BASE_URL###
2009-09-04 | permalink
Dutch biotech firm Pharming said on Thursday it had lodged its application for marketing approval for its lead product Rhucin with the European Medicines Agency (EMEA). [...] But Pharming said it has followed up on and addressed concerns raised by the EMEA during the former evaluation procedure in 2007, adding that the size of the clinical database has been significantly expanded.
2009-09-04 | permalink
Dutch biotech firm Pharming said on Thursday it had lodged its application for marketing approval for its lead product Rhucin with the European Medicines Agency (EMEA). [...] But Pharming said it has followed up on and addressed concerns raised by the EMEA during the former evaluation procedure in 2007, adding that the size of the clinical database has been significantly expanded.
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.